Long-term follow up of serum pepsinogens in patients with gastric cancer or dysplasia afterHelicobacter pylorieradication

Background and Aim Few studies have evaluated the change in serum pepsinogen (sPG) levels after the eradication ofHelicobacter pylori. The aim of this study was to evaluate the effect ofH. pylorieradication on sPG levels in patients with gastric cancer/dysplasia in comparison to a control group. Methods We prospectively enrolled 368 patients with gastric cancer/dysplasia and 610 control subjects.H. pyloristatus and sPG levels were measured before and after eradication. The follow-up time points were classified as < 12, 12-23, 24-35, and >= 36 months. Results In 179H. pylori-eradicated patients with gastric cancer/dysplasia and 168 control group subjects, sPG I significantly decreased, and the sPG I/II ratio significantly increased after eradication compared to baseline, and this improvement in sPG values was maintained during all follow-up time points. Significant differences in sPG I and the sPG I/II ratio were observed between the gastric cancer/dysplasia group and the control group < 24 months after eradication. However, these differences in sPG values disappeared after >= 24 months of follow up. Moreover, significant differences in the intestinal metaplasia grade were observed between these two groups before eradication until < 24 months after eradication. However, these differences in the intestinal metaplasia grade disappeared after >= 24 months of follow up in the corpus. Conclusion The sPG values and intestinal metaplasia grade (corpus) in the gastric cancer/dysplasia group became similar to those in the control group at long-term follow up afterH. pylorieradication. It might be related with the reduction of metachronous gastric neoplasm.